Herbert Loong: I am adopting the use of ctDNA more and more in my GIST practice
Herbert Loong, Clinical Associate Professor at the Chinese University of Hong Kong shared a post by Pawel Sobczuk, Medical oncology fellow at the Maria Skłodowska-Curie National Research Institute of Oncology, on X/Twitter, adding:
“Excellent overview! Thanks Pawel Sobczuk and César Serrano García! I am adopting the use of ctDNA more and more in my GIST practice, esp. when we move between lines of therapies to ensure we have a good assessment of heterogeneity and to ‘tailor’ suitable next TKIs given their differing coverage.”
Quoting Pawel Sobczuk’s post:
“ctDNA in GIST:
ready to use for mutation testing
not read for disease monitoring or detection of MRD (eg. Deciding on duration of adjuvant imatinib re: Tom Wei-Wu Chen) Fantastic overview by César Serrano García “
Source: Herbert Loong/X and Pawel Sobczuk/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023